Group 1 - The company, Chengyi Pharmaceutical Co., Ltd., is convening its second extraordinary general meeting of shareholders in 2025 on September 15, 2025, at 9:30 AM [1][2] - The meeting will be held at the company's R&D building conference room located at 118 Huagong Road, Dongtou District, Wenzhou, Zhejiang Province [1][2] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's shareholder meeting online voting system [1][2][3] Group 2 - The meeting will review non-cumulative voting proposals that have already been approved by the company's fifth board of directors [2] - There are no related shareholders that need to abstain from voting [2] - Shareholders must be registered with the China Securities Depository and Clearing Corporation Limited by the close of business on September 10, 2025, to attend the meeting [4][5] Group 3 - Shareholders can vote through the Shanghai Stock Exchange's online voting system, either via the trading system or the internet voting platform [3][4] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts for the same category of common and preferred shares [4] - The voting process requires that all proposals be voted on before submission [4] Group 4 - The meeting will last for one day, and attendees are responsible for their own accommodation and travel expenses [6] - The company has provided contact information for inquiries related to the meeting [5][6]
诚意药业: 浙江诚意药业股份有限公司关于召开2025年第二次临时股东会的通知